Similar articles

• One year experience with probucol, a new hypocholesterolaemic agent.

  Ng AS, Johan A, Quek SS, Tan IK. Ng AS, et al. Singapore Med J. 1982 Aug;23(4):191-3. Singapore Med J. 1982. PMID: 7178901 No abstract available.
• Effect of probucol on triton induced hyperlipidemias in CFY rats.

  Krishnamurthy A, Thapar GS, Shridhar DR. Krishnamurthy A, et al. Artery. 1985;13(2):87-94. Artery. 1985. PMID: 4084069
• [Probucol in the treatment of hyperlipidemias].

  Feder D, Langer AL, Alexandrino E, Medeiros S, Lotto M, Valente O. Feder D, et al. Arq Bras Cardiol. 1986 Feb;46(2):77-80. Arq Bras Cardiol. 1986. PMID: 3827649 Portuguese. No abstract available.
• Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.

  Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1978 Jun;15(6):409-28. doi: 10.2165/00003495-197815060-00001. Drugs. 1978. PMID: 350557 Review. No abstract available.
• [Diagnosis and treatment of primary hyperlipidemias].

  Davignon J. Davignon J. Arq Bras Cardiol. 1982 Jan;38(1):59-68. Arq Bras Cardiol. 1982. PMID: 6756360 Review. Portuguese. No abstract available.